Aging is a multifaceted process, characterized by diverse health trajectories among individuals. Frailty, a state where the body loses its robustness and becomes more susceptible to various stresses like falls and infections, significantly escalates the risks of hospitalization and mortality. The comprehension of frailty’s varying impact on individuals is pivotal for advancing therapies related to aging.
A recent study titled “Large-scale genome-wide analyses with proteomics integration reveal novel loci and biological insights into frailty” published in Nature Aging by researchers at Karolinska Institutet in Stockholm, undertook a profound genetic investigation involving close to a million individuals from Finland and the U.K. The study unearthed 53 distinct lead genetic variants associated with frailty, with 45 being novel discoveries not previously documented in the genome-wide association study (GWAS) catalog.
Frailty, as defined by the authors, was determined using the Hospital Frailty Risk Score (HFRS), a metric based on 109 weighted International Classification of Diseases codes, aiding in characterizing older adults with high resource utilization and diagnoses linked to frailty. This study marked the first exploration into the genetic foundations of frailty using the HFRS, which was a unique approach.
The research conducted a GWAS in FinnGen, which houses genetic and health data from over 500,000 Finnish biobank contributors. The findings were validated in the UK Biobank, comprising more than 400,000 genomes, at both the individual variant level and through polygenic risk scores. Genes were assessed based on colocalization with expression, splicing, protein quantitative trait loci, and proteomics integration, shedding light on the critical roles of genes such as CGREF1, APOE, and PPP6C in cell functions, Alzheimer’s risk, and innate immunity, respectively.
The study highlights the involvement of immunoinflammatory and nervous system functions in the onset of frailty. The genetic insights gained from this research form a foundation to better predict frailty risks among individuals for age-related therapeutic interventions. Future investigations are poised to delve into the roles of these functions in cognitive frailty development, potentially enabling the identification of at-risk individuals as early as middle age for preventive measures.
Key Takeaways:
– Frailty, characterized by decreased resilience in the body, is associated with heightened risks of hospitalization and mortality.
– A recent study identified 53 genetic variants linked to frailty, with 45 being novel discoveries, emphasizing the multi-genic nature of frailty.
– The study utilized the Hospital Frailty Risk Score (HFRS) to define frailty, providing insights into older adults with high resource utilization and frailty-related diagnoses.
– Genes like CGREF1, APOE, and PPP6C were highlighted for their roles in cell functions, Alzheimer’s risk, and innate immunity, respectively, in the context of frailty.
Tags: immunotherapy, biotech
Read more on genengnews.com